Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Viatrexx-Collagen

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-095-41 D-0335-2020
Class II · Moderate risk

Viatrexx-Infla

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-249-41 D-0334-2020
Class II · Moderate risk

Viatrexx-Neuro 3

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-373-41 D-0333-2020
Class II · Moderate risk

Viatrexx-Articula

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-037-41 D-0332-2020
Class II · Moderate risk

Viatrexx-Systemic Detox

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-500-41 D-0331-2020
Class II · Moderate risk

Viatrexx-Adipose

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-024-41 D-0330-2020
Class II · Moderate risk

Viatrexx-Ithurts

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-270-41 D-0329-2020
Class II · Moderate risk

Viatrexx-Ouch

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-402-41 D-0328-2020
Class II · Moderate risk

Viatrexx-MuSkel-Neural

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-347-41 D-0327-2020
Class II · Moderate risk

Viatrexx-Connectissue

Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

Terminated Sterility / contamination 8046255 Canada Inc. DBA Viatrexx NDC 73069-100-41 D-0326-2020
Class III · Low risk

Levetiracetam Injection

Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.

Terminated Labeling / mix-up X-Gen Pharmaceuticals Inc. NDC 39822-4000-1 D-0519-2020
Class II · Moderate risk

PF-Fentanyl Citrate

GMP Deviations: potential glass contamination

Terminated cGMP deviation Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk

Rifampin for Injection

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Terminated Impurity / degradation Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020

Recalls by year